Mary Cushman Spoke with WPTZ About New Research Showing Incidence of Cognitive Impairment Prediction
Mary Cushman, University Distinguished Professor and Vice Chair at University of Vermont, shared her first post on LinkedIn:
“My 1st LinkedIn post!
I was pleased to speak with WPTZ about our new research showing that circulating laboratory markers of neurodegeneration can predict the incidence of cognitive impairment over 12 years in initially healthy people.
It is amazing to me that damage to the brain can be detected in the blood, and detect pathology occurring years before cognitive problems start.
Associations were larger than I thought they’d be.
This research comes from the REGARDS Study, which we have been conducting since 2003.”
Title: Circulating Biomarkers of Neurodegeneration and Risk of Cognitive Impairment
Authors: Russell P. Sawyer, Aleena Bennett, Jessica Blair, Suzanne E. Judd, Nels Olson, Virginia J. Howard, Nicole D. Armstrong, D. Leann Long, Hyacinth I. Hyacinth, Jennifer J. Manly, Mary Cushman
Read full paper here.
Never miss the latest with Hemostasis Today.
-
Jan 25, 2026, 15:57Céline Chapelle Shares Clinical Predictors From the API-CAT Trial
-
Jan 25, 2026, 15:42Francesco Lo Monaco on Heart Disease Starting Quiet While Your Labs Speak First
-
Jan 25, 2026, 15:33Wilfried Dinh: Why Heart Patients Still Have Events Despite ”Optimal” Cardiovascular Therapy
-
Jan 25, 2026, 15:25Muhammad Ibrahim on Efficacy and Safety of Extended DOACs Use in VTE
-
Jan 25, 2026, 15:08Tushar Pandey on Managing Thrombotic Thrombocytopenic Purpura
-
Jan 25, 2026, 14:55Carolina Contreras Cuevas Shares a Nationwide Study on VTE in PAD
-
Jan 25, 2026, 14:40Jeannie Devereaux Links PRP and Physical Therapy
-
Jan 25, 2026, 14:25Heghine Khachatryan on Anticoagulation After AFib Ablation: New Evidence from NEJM
-
Jan 25, 2026, 12:42Lale Tokgözoğlu on Cardiovascular Risk Factors in Women